Introduction: Cinnamomum oliveri F. M. Bailey is a rain forest tree native to Australia. Decoctions, infusions and essential oils produced from the leaves were used traditionally to treat a variety of bacterial diseases. Despite this, C. oliveri leaf extractions have not been rigorously examined for antibacterial properties against many pathogens. Methods: The antimicrobial activity of C. oliveri leaf extractions was investigated by disc diffusion and growth time course assays against a panel of pathogenic bacteria. The growth inhibitory activity was quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: C. oliveri leaf solvent extractions inhibited the growth of a wide range of bacterial species. Growth of both gram positive and gram negative bacteria was inhibited by the C. oliveri leaf extracts to approximately the same extent. The methanolic extracts were generally most potent growth inhibitors. The methanolic, aqueous and ethyl acetate C. oliveri leaf extracts were particularly potent inhibitors of P. mirabilis growth, with MIC values as low as 127 µg/mL (methanolic extract). A. coli, K. pneumoniae and B. cereus were also particularly susceptible to the methanolic, aqueous and ethyl acetate extracts, with MIC values generally substantially <1000 µg/ mL. The antibacterial activity of the methanolic C. oliveri leaf extract was further investigated by growth time course assays which showed significant growth inhibition in cultures of E. coli, K. pneumoniae and P. mirabilis within 1 h of exposure. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for internal use as well as for topical uses. Conclusions: The lack of toxicity of the C. oliveri leaf extracts and their growth inhibitory bioactivity against a panel of pathogenic bacteria partially validate the traditional usage of these species to treat bacterial diseases and indicate their potential in the development of antiseptic agents.
INTRODUCTION
Plants produce a wide variety of compounds, which in addition to giving them characteristic pigment, odour and flavour characteristics, may also have antimicrobial properties. 1 For thousands of years, traditional plant derived medicines have been used in most parts of the world and their use in fighting microbial disease is becoming the focus of intense study. 2, 3 Whilst much of the research into traditional medicinal plant use has focused on Asian, 4 African 5 and South American 6 plants, the therapeutic potential of the flora of Australia has been recognised for many thousands of years. The first Australians had well developed ethno-pharmacological systems and understood the therapeutic properties of a wide variety of aromatic Australian plants. 7 Despite this, relatively few studies have rigorously examined the antibacterial activity of Australian native plants, although recently there has been increased study in this field. Cinnamomum oliveri F.M.Bailey (family Lauraceae; commonly known as camphorwood, Oliver's sassafras, black sassafras and cinnamon wood) is a medium-large tree which is native to rainforest regions of north eastern Australia. The trees grow 25 m tall with buttressed trunks. The glossy green leaves (Figure 1a ) are lanceolate with wavy margins and grow to 15 cm long by 4 cm wide. When broken, the leaves and twigs emit a sarsaparilla-like odour. White to cream flowers are produced in panicles approximately 6 mm long (Figure 1b) . The flowers develop into small aromatic drupes to approximately 12 mm (Figure 1c ) which ripen to a glossy black colour. Interestingly, Australian Aborigines used bark decoctions to treat diarrhoea and dysentery and several other bacterial diseases. 7 Despite this, antibacterial studies of Cinnamomum oliveri leaves are lacking. Several interesting phytochemical components have been identified in C. oliveri leaves. In particular, several terpenoids components have been isolated from C. oliveri leaf and bark and identified as camphor ( and cinnamic aldehyde (Figure 1h ). Growth inhibitory properties have previously been reported for many of these terpenoids against several bacteria. 8 Despite these promising studies, examination of the antibacterial properties and phytochemistry of the leaves from C. oliveri is lacking. The current report was undertaken to screen C. olioveri leaf extracts for growth inhibitory properties against a panel of pathogenic bacteria. 
MATERIALS AND METHODS

Plant collection and extraction
Cinnamomum oliveri F.M.Bailey leaves were obtained from and identified by Philip Cameron, senior botanic officer, Mt Cootha Botanical Gardens, Brisbane, Australia. Leaf samples were dried in a Sunbeam food dehydrator and stored at -30 o C. Prior to use, the leaves were freshly ground to a coarse powder and 1 g quantities were weighed into separate tubes. A volume of 50 mL methanol, sterile deionised water, ethyl acetate, chloroform or hexane was added to individual tubes and extracted for 24 h at 4 o C with gentle shaking. All solvents were obtained from Ajax, Australia and were AR grade. The extracts were filtered through filter paper (Whatman No. 54) under vacuum, followed by drying by rotary evaporation in an Eppendorf concentrator 5301. The resultant pellets were dissolved in 10 mL sterile deionised water (containing 1 % DMSO). The extracts were passed through 0.22 µm filter (Sarstedt) and stored at 4 o C until use.
Qualitative phytochemical studies
Phytochemical analysis of the C. oliveri leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by previously described assays.
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Antibacterial screening 
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay. [12] [13] [14] Briefly, 100 µL of each bacterial culture was grown in 10 mL of fresh nutrient broth until they reached a count of ~10 8 cells/mL. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar plates and extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of the plant extracts, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4 °C for 2 h before incubation at 30 °C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10 µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10 µL of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of each extract against susceptible bacteria was determined as previously described. 15, 16 Briefly, the C. oliveri extracts were diluted in deionised water and tested across a range of concentrations. Discs were infused with 10 µL of the test dilutions, allowed to dry and placed onto inoculated plates. The assay was completed as outlined above and graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to determine the MIC values of each extract.
Bacterial growth time course assay
Bacterial growth time course studies were performed as previously described. 17, 18 Briefly, 3 mL of the E. coli, K. pneumoniae and P. mirabilis bacterial cultures in nutrient broth were added individually to 27 mL nutrient broth containing 3 mL of 10 mg/mL methanolic plant extract to give a final concentration of 1000 µg/mL in the assay. The tubes were incubated at 30 o C with gentle shaking. The optical density was measured hourly at 550 nm for a 6 h incubation period. Control tubes were incubated under the same conditions but without the extract. All assays were performed in triplicate.
Toxicity screening
Reference toxin for toxicity screening Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 4 mg/mL solution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [19] [20] [21] Briefly, 400 µL of seawater containing approximately 46 (mean 46.3, n = 75, SD 11.6) A. franciscana nauplii were added to wells of a 48 well plate and immediately used for bioassay. A volume of 400 µL of diluted plant extracts or the reference toxin were transferred to the wells and incubated at 25 ± 1 o C under artificial light (1000 Lux). A 400 µL seawater negative control was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was detected within 10 seconds. After 24 h, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was determined using probit analysis.
Statistical analysis
Data are expressed as the mean ± SEM of at least three independent experiments. One way ANOVA was used to calculate statistical significance between control and treated groups with a P value < 0.01 considered to be statistically significant.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1 g of dried and powdered C. oliveri leaves with solvents of varying polarity yielded dried extracts ranging from 53 mg (ethyl acetate extract) to 164 mg (chloroform extract) ( Table 1 ). The aqueous (145 mg) and methanolic extracts (104 mg) also yielded relatively high levels of extracted materials. The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO), resulting in the extract concentrations shown in Table 1 . Qualitative phytochemical studies showed that the high to mid polarity methanol, water and ethyl acetate solvents extracted the greatest diversity and highest levels of phytochemicals. These extracts contained high levels of water soluble phenolics and flavonoids, and low levels of triterpenoids. The aqueous and ethyl acetate extracts also contained low levels of alkaloids. Interestingly, despite extracting relatively large amounts of material, the chloroform and hexane extracts were devoid of all classes of phytochemicals screened. Due to their nonpolar nature, these extracts would be expected to contain high levels of lipids, hydrocarbons etc. As our qualitative phytochemical studies did not screen for these compounds, they were not detected. Other techniques are required to further examine the nature of these nonpolar components.
Antimicrobial activity
To determine the growth inhibitory activity of the C. oliveri leaf extracts against the panel of pathogenic bacteria, aliquots (10 µL) of each extract were screened in the disc diffusion assay. The C. oliveri leaf extracts were potent inhibitors of several gram negative bacterial species (Figure 2 ). Of the 10 gram negative bacterial strains tested, 3 (30 %) were inhibited by all C. oliveri leaf extracts. E. coli, K. pneumoniae and P. mirabilis were highly susceptible to the C. oliveri extracts. Indeed, the growth of these bacteria was inhibited by all of the C. oliveri extracts. The higher polarity methanolic and aqueous extracts were the most potent bacterial growth inhibitors against most susceptible bacterial species compared 
+++ indicates a large response; ++ indicates a moderate response; + indicates a minor response; -indicates no response in the assay. All bioassays were performed in at least triplicate and are expressed as mean ± SEM. * = growth results in the presence of the methanolic extract that are significantly different to the untreated control growth (p<0.01); # = growth results in the presence of the aqueous extract that are significantly different to the untreated control growth (p<0.01). The lethality of the C. oliveri leaf extracts (2000 µg/mL), potassium dichromate (1000 µg/mL) and a seawater control. Blue bars represent the % mortality following 24 h exposure to the extract/toxin. Green bars represent the % mortality following 48 h exposure to the extract/ toxin. NC = negative (seawater) control; PC = positive control (1000 µg/ mL potassium dichromate). All bioassays were performed in at least triplicate and are expressed as mean ± SEM.
with the lower polarity extracts (as assessed by the sizes of the zones of inhibition). The methanolic C. oliveri extract strongly inhibited E. coli and P. mirabilis growth with 11.3 ± 1.2 mm and 14.3 ± 1.2 mm zones of inhibition respectively. The aqueous extract was similarly potent with 10 ± 1 mm and 10.6 ± 0.6 mm zones of inhibition against E. coli and P. mirabilis respectively. This inhibition was particularly noteworthy compared to the inhibition by the ampicillin (10 µg: inhibition zones of 8.6 ± 0.6 mm and 10.3 ± 0.3 mm) and chloramphenicol controls (2 µg: inhibition zones of 8.6 ± 0.3 mm and 9.6 ± 0.6 mm respectively).
The growth of some gram positive bacteria was also inhibited by the C. oliveri leaf extracts (Figure 3 ). The growth of 2 of the 4 gram positive bacteria species screened (50 %) was inhibited by the C. oliveri leaf extracts. However, in general, only the methanolic and aqueous C. oliveri leaf extracts inhibited the growth of the gram positive bacteria. Furthermore, the inhibition of gram positive bacterial growth appeared substantially less potent than was the inhibition of gram negative growth (as deter-mined by zone of inhibition. The antimicrobial efficacy was further quantified by determining the MIC values for each extract against the microbial species which were determined to be susceptible. The methanolic, aqueous and ethyl acetate C. oliveri leaf extracts were potent growth inhibitors of several bacterial species (as judged by MIC; Table 2 ). P. mirabilis was the most susceptible bacteria to the C. oliveri leaf extracts, with MIC values as low as 127 µg/mL for the methanolic extract (approximately 1 µg infused into the disc) recorded for against this bacteria. The MIC values determined for the aqueous and ethyl acetate extract against P. mirabilis also indicate potent growth inhibition (525 and 688 µg/mL respectively). As P. mirabilis infection is a common cause of urinary tract infections and has also been identified as a trigger of rheumatoid arthritis, 22, 23 the aqueous and methanolic C. oliveri extracts have potential for the prevention aqnd treatment of these diseases in genetically susceptible individuals. Furthermore, the aqueous, methanolic and ethyl acetate C. oliveri leaf extracts were also potent E. coli and K. pneumomiae growth inhibitors, with MIC values generally in the 200-700 µg/mL range. As K. pneumoniae can trigger ankylosing spondylitis in genetically susceptible individuals, 24, 25 these extracts may also be useful in the prevention and treatment of this disease. The aqueous and methanolic C. oliveri leaf extracts were also good B. cereus growth inhibitors (MIC <700 µg/mL). Moderate to low growth inhibition (or no inhibition) was noted for all other extract/bacterium combinations.
Bacterial growth time course assay
The antibacterial activity of the C. oliveri extracts was further investigated in the most susceptible bacterial species (E. coli, K. pneumoniae, P. mirabilis) by bacterial growth time course assays in the presence and absence of the extract. Only the effect of the methanolic extract on the bacterial growth time courses was evaluated as this extract was generally more potent than the other C. oliveri extracts. The starting concentration of the extract used in these assays was 1000 µg/mL. The methanolic C. oliveri extract significantly inhibited E. coli (Figure 4a ), K. pneumoniae ( Figure 4b ) and P. mirabilis (Figure 4c ) growth within 1 h, indicating a rapid antimicrobial action. Whilst both E. coli and K. pneumoniae growth was inhibited for at least the first 4 hours of the time course, the bacteria were generally able to overcome this inhibition by 6h, with the recorded turbidity not significantly different to that of the untreated control. This indicates that the growth inhibition of these bacteria was bacteriostatic for the methanolic C. oliveri extract at the concentrations tested against these bacteria. In contrast, inhibition of P. mirabilis by the methanolic C. oliveri extract was substantially more profound, with growth still significantly inhibited by the end of the 6 h time course study. Indeed, the turbidity in the presence of the methanolic extract at 6 h was not greatly increased from the starting turbidity. In contrast, the aqueous extract did not completely inhibit P. mirabilis growth and levels approaching those seen in the untreated control were evident by 6h. This may indicate that the aqueous extract is bacteriostatic, whilst the methanolic C. oliveri has bactericidal activity against P. mirabilis at the dose tested.
Quantification of toxicity
The toxicity of the C. oliveri extracts was initially tested in the Artemia franciscana nauplii bioassay at a concentration of 2000 µg/mL ( Figure 5 ). The aqueous and methanolic extracts induced >50 % mortality at 24 h and were thus deemed to be toxic. All other extracts induced low levels of mortality at 24 h, similar to the % mortality seen for the seawater control. By 48 h, the aqueous and methanolic extracts had induced approximately 100% mortality. Whilst mortality induction by the ethyl acetate and chloroform extracts was significantly higher than that in the untreated control following 48 h exposure, the levels were still <50 % and thus were deemed to be nontoxic. In contrast, the potassium dichromate positive control induced mortality within 4 h (results not shown), with 100 % mortality induction seen by 24 h. To further quantify the effect of toxin concentration on the induction of mortality, the extracts were serially diluted in artificial seawater to test across a range of concentrations in the Artemia nauplii bioassay (Table  3) . For comparison, serial dilutions of potassium dichromate were also tested. All extracts were determined to be nontoxic, with LC 50 values substantially greater than 1000 µg/mL following 24 h exposure. Extracts with an LC 50 of greater than 1000 µg/mL towards Artemia nauplii have previously been defined as being nontoxic.
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DISCUSSION
Plant derived remedies are becoming increasingly sought after in the treatment of a myriad of diseases and disorders due both to their perception of greater safety than synthetic drugs, and the failure of current drug regimens to effectively treat many diseases. Our study reports on the growth inhibitory properties of C. oliveri leaf extracts against a panel of pathogenic bacteria, and on their toxicity. The gram positive and gram negative bacteria tested in this study demonstrated similar susceptibilities towards the C. oliveri leaf extracts. In contrast, many previous studies with other plant species report a greater susceptibility of many bacterial species towards solvent extracts for South American, 26 African 27 and Australian plant extracts. 28, 29 Our study examined the ability of C. oliveri leaf extracts to inhibit the growth of a panel of medicinally important bacterial pathogens. The methanolic and aqueous extracts were identified as being particularly potent inhibitors of P. mirabilis with MIC values of 127 and 525 µg/mL respectively. The ethyl acetate extract and chloroform extracts were also good P. mirabilis growth inhibitors, albeit with higher MIC values (688, 987 and 1066 µg/mL respectively). As P. mirabilis can trigger rheumatoid Results represent the mean ± SEM of triplicate determinations. CND indicates that a LC 50 could not be determined as the mortality did not exceed 50 % at any concentration tested.
arthritis in genetically susceptible individuals, 22, 23 these extracts have potential for the development of rheumatoid arthritis inhibitory therapies. The methanolic and aqueous extract also displayed potent K. pneumoniae growth inhibitory properties, with MIC values 686 and 706 µg/mL respectively. The ethyl acetate, chloroform and hexane extracts were also moderate-good K. pneumoniae growth inhibitors with MIC values <1500 µg/mL. As K. pneumoniae can trigger ankylosing spondylitis in genetically susceptible individuals, 30, 31 this extract may also be useful in the prevention and treatment of ankylosing spondylitis. Whilst not as potent, the methanolic and aqueous C. oliveri extracts were moderate inhibitors of S. pyogenes growth (MICs of 1680 and 2263 µg/mL respectively). C. oliveri leaf extracts also inhibited the growth of several bacterial species associated with food poisoning. The methanolic, aqueous and ethyl acetate extracts were particularly potent inhibitors of growth of E. coli growth, with MIC values of 215, 427 and 330 µg/mL respectively. The chloroform and hexane extracts were also moderate E. coli growth inhibitors, albeit with higher MIC values (1255 and 1438 µg/ mL respectively). Similarly, the methanolic and aqueous C. oliveri leaf extracts were potent inhibitors of B. cereus growth (MIC <1000 µg/mL), and the ethyl acetate extract was a moderate growth inhibitor (MIC = 1500 µg/mL). Therefore, the C. oliveri leaf extracts have therapeutic potential in the treatment of food poisoning, diarrhoea and dysentery. Whilst a detailed investigation of the phytochemistry of the C. oliveri leaf extracts was beyond the scope of our study, qualitative screening studies were used to determine the classes of compounds present. Some commonalities were noted: the most potent aqueous and methanolic extracts all contained relatively high levels of total phenolics and flavonoids. It is likely that these and other phytochemical classes may contribute to the growth inhibitory properties of these extracts. Our qualitative phytochemical screening studies also indicated that triterpenoids, phytosterols and saponins were present in the C. oliveri leaf extracts. Many studies have reported potent antibacterial activities for a wide variety of these compounds. 8 Further phytochemical evaluation studies and bioactivity driven isolation of active components is required to further evaluate the mechanism of bacterial growth inhibition. The findings reported here also demonstrate that all of the C. oliveri leaf extracts were nontoxic towards Artemia franciscana nauplii, with LC 50 values substantially > 1000 µg/mL. Extracts with LC 50 values > 1000 µg/ mL towards Artemia nauplii are defined as being nontoxic. 21 Whilst our preliminary toxicity studies indicate that these extracts may be safe for therapeutic use, studies using human cell lines are required to further evaluate the safety of these extracts. Furthermore, whilst these studies have demonstrated the potential of the C. oliveri leaf extracts in the development of future antibiotic chemotherapeutics for the prevention and treatment of urinary tract infections, autoimmune diseases (particularly rheumatoid arthritis and ankylosing spondylitis), more work is required to isolate the inhibitory components and determine the mechanism of inhibition.
CONCLUSIONS
The results of this study demonstrate the potential of the C. oliveri leaf extracts as inhibitors of pathogenic bacteria growth. Furthermore, their lack of toxicity indicates than they are safe for internal as well as topical treatment. Further studies aimed at the purification and identification of bioactive components are required to examine the mechanisms of action of these agents.
